ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0614

Post-translationally Modified Fibrinogen Activated Macrophages Drive the Expression of Fibrotic Genes in Rheumatoid Arthritis Fibroblast-Like Synoviocytes

nozima Aripova1, Michael Duryee1, carlos hunter1, Eric Daubach1, Evan Ryan1, Geoffrey Thiele1 and Ted Mikuls2, 1University of Nebraska Medical Center, Omaha, NE, 2Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

Meeting: ACR Convergence 2022

Keywords: chemokines, Fibroblasts, Synovial, Gene Expression, Inflammation, macrophages

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Cellular interactions between synovial macrophages and human fibroblast-like synoviocytes (HFLS) contribute to articular inflammation and fibrosis in rheumatoid arthritis (RA), leading to subsequent joint destruction. We have previously shown that malondialdehyde-acetaldehyde (MAA) and citrulline (CIT) modified antigens co-localize in RA synovial tissues. However, the mechanisms by which MAA and CIT modified proteins affect cellular interactions between macrophages and fibroblasts have not been well delineated. The purpose of this study was to identify fibrotic gene expression by HFLS-RA cells in response to: 1) Direct stimulation with MAA and/or CIT modified fibrinogen (FIB); or, 2) Indirect stimulation using secreted soluble factors from macrophages stimulated with MAA and/or CIT modified FIB.

Methods: In a previous study of HFLS-RA cells, the expression of 763 genes using the NanoString® Human Fibrosis Panel was evaluated and top 9 genes expressed were used for further evaluation (Maloley P et.al, 2021). In this study, HFLS-RA cell line was treated with either MAA and/or CIT modified FIB or with supernatants from human macrophage (U-937 cells) that had been collected after stimulation with modified FIB. RNA was isolated 8 hours post-treatment to determine the mRNA levels using RT-PCR. Genes were categorized into four groups (inflammation, initiation, modification, and proliferation) based on their role in the fibrotic pathway, with several genes exerting influence on multiple pathways. The mean of the relative quantity (Rq) of expression for each gene was reported. All the values were compared to the stimulation with native FIB.

Results: Direct antigen stimulation of HFLS-RA with FIB-CIT demonstrated an amplification of inflammation and initiation genes (Fig.1); MMP-9 (2-fold, p< 0.001 vs. FIB), IL-1β (12-fold, p< 0.001), IL-6 (26-fold, p< 0.001), and FGF2 (4-fold, p< 0.001). HFLS-RA treated with FIB-MAA-CIT amplified the same genes as FIB-CIT, but to a lesser extent. Direct stimulation of HFLS-RA with FIB-MAA significantly decreased IL-1β and IL-6 gene expression (Fig.1). In contrast, exposure of HFLS-RA to macrophage supernatants generated from stimulation with FIB-CIT or FIB-MAA-CIT led to increased expression of modification and proliferation genes; MMP-9, MMP-10, MMP-12, FGF2, EGR1, and PDGFB (Fig.2). When HFLS-RA were treated with U937 supernatants from FIB-MAA stimulated macrophages, MMP-9, IL-1β, IL-6, EGR1, PDGFB, and MMP-10, MMP-12 genes were increased compared to native FIB.

Conclusion: Our studies demonstrate that HFLS-RA cells exposed to MAA and/or CIT modified FIB primarily upregulated markers of inflammation and initiation. However, treatment with macrophage supernatants generated following stimulation with the same modified antigens shifted fibroblast gene expression towards modification and proliferation. These studies showed clearly differentiated responses that both direct antigen stimulation and macrophage interactions are necessary to engage all 4 relevant pathways involved in fibroblast-mediated joint damage that characterizes RA.

Supporting image 1

Figure 1. PCR for mRNA levels of inflammation and initiation fibrosis markers from stimulated HFLS-RA cells. HFLS-RA cells were stimulated with either supernatants from modified antigens treated U937 cells or with directly modified antigens. The data is represented as mean (standard deviation) of relative quantity (Rq) of fibrosis markers. All the values are compared to native protein. #p<0.05, *p<0.001, n=3.

Supporting image 2

Figure 2. PCR for mRNA levels of modification and proliferation fibrosis markers from stimulated HFLS-RA cells. HFLS-RA cells were stimulated with either supernatants from modified antigens treated U937 cells or with directly modified antigens. The data is represented as mean (standard deviation) of relative quantity (Rq) of fibrosis markers. All the values are compared to native protein. #p<0.05, *p<0.001, n=3.


Disclosures: n. Aripova, None; M. Duryee, None; c. hunter, None; E. Daubach, None; E. Ryan, None; G. Thiele, None; T. Mikuls, Gilead Sciences, Bristol-Myers Squibb, Horizon, Sanofi, Pfizer Inc.

To cite this abstract in AMA style:

Aripova n, Duryee M, hunter c, Daubach E, Ryan E, Thiele G, Mikuls T. Post-translationally Modified Fibrinogen Activated Macrophages Drive the Expression of Fibrotic Genes in Rheumatoid Arthritis Fibroblast-Like Synoviocytes [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/post-translationally-modified-fibrinogen-activated-macrophages-drive-the-expression-of-fibrotic-genes-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/post-translationally-modified-fibrinogen-activated-macrophages-drive-the-expression-of-fibrotic-genes-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology